Search

everythinglearnresearchcommunity

for

Search:↓

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

New compounds may help treat prostate cancer by reducing cell growth.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

The triterpenoids from Ganoderma lucidum can block testosterone effects and may help treat enlarged prostate.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Vitamin E affects liver metabolism, enhancing stress resistance, reducing blood clotting, and altering hormone processing.

Finasteride significantly reduces DHT levels in male dogs without affecting testosterone levels, suggesting it could be used to treat benign prostatic hypertrophy in dogs weighing 10 to 50 kilograms.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

Finasteride doesn't affect erections much, but may decrease libido in men.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Testosterone is crucial for development, growth, and various body functions in mammals.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

Finasteride treats hair loss and reduces prostate cancer risk.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.